MYGN
Myriad Genetics Inc
Price:  
14.65 
USD
Volume:  
1,864,993.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MYGN Relative Valuation

-280.9%
Upside

As of 2025-02-14, the Relative Valuation of Myriad Genetics Inc (MYGN) is (26.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.65 USD, the upside of Myriad Genetics Inc based on Relative Valuation is -280.9%.

The range of the Relative Valuation is (22.32) - (30.38) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 14.4x - 23.8x 16.8x
Forward P/E multiples 17.5x - 25.4x 24.8x
Fair Price (22.32) - (30.38) (26.50)
Upside -252.4% - -307.3% -280.9%
14.65 USD
Stock Price
(26.50) USD
Fair Price

MYGN Relative Valuation - Historical P/E Data

Date P/E
2025-02-07 -9.74
2025-02-06 -9.99
2025-02-05 -10.15
2025-02-04 -9.74
2025-02-03 -10.02
2025-01-31 -9.94
2025-01-30 -10.13
2025-01-29 -9.84
2025-01-28 -9.81
2025-01-27 -10.17
2025-01-24 -10.06
2025-01-23 -10.01
2025-01-22 -9.64
2025-01-21 -9.87
2025-01-17 -9.72
2025-01-16 -9.83
2025-01-15 -10.32
2025-01-14 -10.74
2025-01-13 -11.21
2025-01-10 -11.64
2025-01-08 -11.60
2025-01-07 -11.22
2025-01-06 -10.81
2025-01-03 -10.73
2025-01-02 -10.60
2024-12-31 -10.76
2024-12-30 -10.70
2024-12-27 -10.53
2024-12-26 -10.60
2024-12-24 -10.78
2024-12-23 -10.71
2024-12-20 -10.49
2024-12-19 -10.34
2024-12-18 -10.40
2024-12-17 -10.85
2024-12-16 -11.08
2024-12-13 -11.33
2024-12-12 -11.38
2024-12-11 -11.39
2024-12-10 -12.04
2024-12-09 -11.68
2024-12-06 -11.87
2024-12-05 -12.84
2024-12-04 -13.03
2024-12-03 -12.74
2024-12-02 -13.10
2024-11-29 -12.77
2024-11-27 -12.78
2024-11-26 -12.69
2024-11-25 -12.33